Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 689,682
  • Shares Outstanding, K 40,028
  • Annual Sales, $ 13,470 K
  • Annual Income, $ -74,010 K
  • 60-Month Beta 2.26
  • Price/Sales 33.67
  • Price/Cash Flow N/A
  • Price/Book 3.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.62
  • Number of Estimates 6
  • High Estimate -0.41
  • Low Estimate -0.78
  • Prior Year -0.52
  • Growth Rate Est. (year over year) -19.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.49 +5.62%
on 01/27/20
17.85 -8.35%
on 02/18/20
+0.31 (+1.93%)
since 01/24/20
3-Month
14.77 +10.73%
on 01/06/20
26.67 -38.66%
on 11/29/19
-7.71 (-32.03%)
since 11/22/19
52-Week
14.77 +10.73%
on 01/06/20
27.55 -40.62%
on 07/17/19
-0.59 (-3.48%)
since 02/22/19

Most Recent Stories

More News
Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa...

CARA : 16.36 (-5.05%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (LJPC , CVM, CARA , XNCR , CYTK )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

CARA : 16.36 (-5.05%)
LJPC : 7.22 (-11.08%)
Cara Therapeutic Set to Possibly Pullback After Yesterday's Rally of 2.50%

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $15.48 to a high of $15.95. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high...

CARA : 16.36 (-5.05%)
Cara Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus by selectively targeting peripheral...

JPM : 132.16 (-2.69%)
CARA : 16.36 (-5.05%)
Cara Therapeutic Set to Possibly Pullback After Yesterday's Rally of 1.49%

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $16.75 to a high of $17.28. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high...

CARA : 16.36 (-5.05%)
Cara Therapeutic Set to Possibly Pullback After Yesterday's Rally of 4.21%

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $16.49 to a high of $17.61. Yesterday, the shares gained 4.2%, which took the trading range above the 3-day high...

CARA : 16.36 (-5.05%)
Cara Therapeutics Announces Equity Grants to Employees Under Inducement Plan

Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa...

CARA : 16.36 (-5.05%)
Biotech Stock Roundup: Pipeline Updates From BIIB, AXSM, CARA, Collaborations & More

Key highlights of the past week include regulatory and pipeline updates along with collaboration deals.

MRK : 81.33 (-1.23%)
SGEN : 116.00 (-0.85%)
CARA : 16.36 (-5.05%)
BIIB : 325.98 (-3.19%)
AXSM : 88.51 (-2.88%)
INCY : 78.87 (-2.50%)
Cara Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus by selectively targeting peripheral...

CARA : 16.36 (-5.05%)
Look for Shares of Cara Therapeutic to Potentially Rebound after Yesterday's 27.55% Sell Off

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $17.58 to a high of $20.69. Yesterday, the shares fell 27.6%, which took the trading range below the 3-day low of...

CARA : 16.36 (-5.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CARA with:

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

2nd Resistance Point 16.89
1st Resistance Point 16.63
Last Price 16.36
1st Support Level 16.18
2nd Support Level 15.99

See More

52-Week High 27.55
Fibonacci 61.8% 22.67
Fibonacci 50% 21.16
Fibonacci 38.2% 19.66
Last Price 16.36
52-Week Low 14.77

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar